We have identified BM212 as a lead compound among a series of pyrrole derivatives with good in vitro activity against mycobacteria and candidae. First studies led us to synthesize some pyrrole compounds in which the thiomorpholine fragment was present. Some compounds revealed very active and these findings prompted us to prepare new pyrrole derivatives 2-15 in the hope of increasing the activity. The microbiological data showed interesting in vitro activity against Mycobacterium tuberculosis and atypical mycobacteria.
Biava, M., Porretta, G.C., Deidda, D., Pompei, R., Tafi, A., Manetti, F. (2004). Antimycobacterial compounds. New pyrrole derivatives of BM212. BIOORGANIC & MEDICINAL CHEMISTRY, 12(6), 1453-1458 [10.1016/j.bmc.2003.12.037].
Antimycobacterial compounds. New pyrrole derivatives of BM212
TAFI, ANDREA;MANETTI, FABRIZIO
2004-01-01
Abstract
We have identified BM212 as a lead compound among a series of pyrrole derivatives with good in vitro activity against mycobacteria and candidae. First studies led us to synthesize some pyrrole compounds in which the thiomorpholine fragment was present. Some compounds revealed very active and these findings prompted us to prepare new pyrrole derivatives 2-15 in the hope of increasing the activity. The microbiological data showed interesting in vitro activity against Mycobacterium tuberculosis and atypical mycobacteria.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2004BioorgMedChemAntiTBpirroli.pdf
non disponibili
Tipologia:
Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
311.28 kB
Formato
Adobe PDF
|
311.28 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
https://hdl.handle.net/11365/24135
Attenzione
Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo